Standout Papers

Survival impact of complete cytoreduction to no gross residual disease for advanced-stage ovarian ... 2013 2026 2017 2021 310
  1. Survival impact of complete cytoreduction to no gross residual disease for advanced-stage ovarian cancer: A meta-analysis (2013)
    Suk‐Joon Chang, Melissa Hodeib et al. Gynecologic Oncology

Immediate Impact

1 from Science/Nature 53 standout
Sub-graph 1 of 23

Citing Papers

Role of SLC7A11/xCT in Ovarian Cancer
2024 Standout
Comparative Effectiveness and Cost-Effectiveness of Colorectal Cancer Screening With Blood-Based Biomarkers (Liquid Biopsy) vs Fecal Tests or Colonoscopy
2024 Standout
2 intermediate papers

Works of Melissa Hodeib being referenced

Impact of COVID-19 on Cervical Cancer Screening Rates Among Women Aged 21–65 Years in a Large Integrated Health Care System — Southern California, January 1–September 30, 2019, and January 1–September 30, 2020
2021
Survival impact of complete cytoreduction to no gross residual disease for advanced-stage ovarian cancer: A meta-analysis
2013 Standout

Author Peers

Author Last Decade Papers Cites
Melissa Hodeib 203 327 262 25 623
Leslie Bradford 224 226 194 46 680
Roni Nitecki 168 316 160 49 664
Scott Kamelle 158 232 220 23 717
Clare J. Reade 112 264 125 34 544
H. J. Solomon 98 230 194 15 624
Ron E. Swensen 180 213 178 29 529
Andrea Miranda 103 367 215 39 680
Meaghan Tenney 131 193 120 27 548
Tine Henrichsen Schnack 106 306 253 44 683
Guus Fons 256 124 190 31 723

All Works

Loading papers...

Rankless by CCL
2026